Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.74 |
| ▸ | DRD4 | P21917 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | DRD2 | P14416 | 1/20 | 0.68 |
| ▸ | DRD3 | P35462 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.64 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.64 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1781392 | 0.91 | DRD4 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL7393471 | 0.91 | DRD4 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL7500995 | 0.91 | DRD4 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL2425554 | 0.88 | SIGMAR1 (0.78) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL6750438 | 0.87 | SIGMAR1 (0.77) | SIGMAR1POLB | |
| SCHEMBL12184810 | 0.87 | SIGMAR1 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL22634135 | 0.87 | SIGMAR1 (0.63) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| Hydrochloric Acid SCHEMBL21410212 | 0.86 | SIGMAR1 (0.76) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL5175893 | 0.86 | MCHR1 (0.72) | SIGMAR1POLBMCHR1 | |
| SCHEMBL4592089 | 0.85 | SIGMAR1 (0.68) | SIGMAR1DRD4KMT2AMCHR1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2617779-B1 | Low odor environmentally-friendly nano-pigment inkjet ink composition | JETBEST CORP (TW) | 2014-11-05 | — | — | EP | claimed |
| US-8710118-B2 | Nano-pigment inkjet ink composition that has a low odor and is environmentally-friendly | JETBEST CORPORATION (TW) | 2014-04-29 | — | — | US | claimed |
| US-20130190421-A1 | LOW ODOR ENVIRONMENTALLY-FRIENDLY NANO-PIGMENT INKJET INK COMPOSITION | JETBEST CORPORATION (TW) | 2013-07-25 | — | — | US | claimed |
| EP-2617779-A1 | Low odor environmentally-friendly nano-pigment inkjet ink composition | JETBEST Corporation (TW) | 2013-07-24 | — | — | EP | claimed |
| EP-0238357-B1 | 1,2,4-TRIAZINONE DERIVATIVES, THEIR PREPARATION AND USE | Sankyo Company Limited (JP) | 1991-05-29 | — | — | EP | claimed |
| US-12631983-B2 | Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12421396-B2 | Silica particles and method for producing the same | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-4343440-B1 | ELECTROSTATIC IMAGE DEVELOPER, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP (JP) | 2025-04-23 | — | — | EP | disclosed |
| US-12077443-B2 | Silica particles and method for producing the same | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2024-09-03 | — | — | US | disclosed |
| EP-4403519-A1 | SILICA PARTICLE, TONER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE, AND ELECTROSTATIC CHARGE IMAGE DEVELOPER | FUJIFILM Business Innovation Corp. (JP) | 2024-07-24 | — | — | EP | disclosed |
| EP-4371938-A2 | SILICA PARTICLE, TONER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM Business Innovation Corp. (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-20240134299-A1 | ELECTROSTATIC IMAGE DEVELOPER, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2024-04-25 | — | — | US | disclosed |
| EP-0526342-B1 | Isoquinolin-5yl-sulphonamides, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1996-12-04 | — | — | EP | disclosed |
| US-5563141-A | INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION | ZENECA LIMITED (GB) | 1996-10-08 | — | — | US | disclosed |
| US-5556977-A | ANTIAGGLOMERANTS FOR CELLS, ANTICOAGULANTS, ANTIISCHEMIC AGENTS USING PYRIDINYLPIPERAZINE DERIVATIVES | ZENECA LIMITED (GB) | 1996-09-17 | — | — | US | disclosed |
| US-5208243-A | Analgesics | ADIR ET COMPAGNIE (FR) | 1993-05-04 | — | — | US | disclosed |
| EP-0526342-A1 | Isoquinolin-5yl-sulphonamides, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1993-02-03 | — | — | EP | disclosed |
| EP-0238357-B1 | 1,2,4-TRIAZINONE DERIVATIVES, THEIR PREPARATION AND USE | Sankyo Company Limited (JP) | 1991-05-29 | — | — | EP | disclosed |
| US-4711890-A | TREATMENT OF ANXIETY STATES OR OF PULMONARY, RENAL, CIRCULATORY OF CARDIOVASCULAR DISORDERS | RHONE-POULENC SANTE (FR) | 1987-12-08 | — | — | US | disclosed |
| US-4684652-A | TREATING ANXIETY OR CARDIOVASCULAR DISORDERS | RHONE-POULENC SANTE (FR) | 1987-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12631983-B2 | Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | BET1, SMARCC1, SMARCC2 | SIGMAR1 457/4885DRD4 4187/4885KMT2A 2700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.